Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Lung Cancer (Amsterdam, Netherlands)|April 5, 2016
Successful treatment with ceritinib after crizotinib induced hepatitisMarion Sassier, Bertrand Mennecier, Anthony Gschwend, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 7, 2017
Retrospective evaluation of concomitant cetuximab and radiotherapy tolerance for locoregional advanced head and neck squamous cell carcinoma treatment in patients unfit for platinum-based chemotherapyAudrey Rambeau, Radj Gervais, Dominique De Raucourt, et al.
The Annals of Thoracic Surgery|April 9, 2013
Does bilobectomy offer satisfactory long-term survival outcome for non-small cell lung cancer?Philippe Icard, Maxime Heyndrickx, Françoise Galateau-Sallé, et al.
Targeted Oncology|June 19, 2017
Targeting the PD-1/PD-L1 Immune Checkpoint in EGFR-Mutated or ALK-Translocated Non-Small-Cell Lung CancerOlivier Bylicki, Nicolas Paleiron, Jacques Margery, et al.
Expert Review of Anticancer Therapy|September 4, 2018
Oral vinorelbine-based concomitant chemoradiotherapy in unresectable stage III non-small cell lung cancer: a systematic reviewPaul Lesueur, Isabelle Martel-Laffay, Alexandre Escande, et al.
Lung Cancer (Amsterdam, Netherlands)|February 26, 2013
Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): a phase II trialRadj Gervais, Gilles Robinet, Christelle Clément-Duchêne, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2005
A randomised phase II study of the efficacy and safety of intravenous topotecan in combination with either cisplatin or etoposide in patients with untreated extensive disease small-cell lung cancerElisabeth Quoix, Jean-Luc Breton, Radj Gervais, et al.
Journal of Gastrointestinal Oncology|July 13, 2018
Oxaliplatin-induced bronchiolitis obliterans organizing pneumonia following hyperthermic intraperitoneal chemotherapyGuillaume Le Baut, Jean-Marc Guilloit, Vincent Leprince, et al.
Clinical Lung Cancer|December 4, 2014
Second-line oral chemotherapy (lomustine, cyclophosphamide, etoposide) versus intravenous therapy (cyclophosphamide, doxorubicin, and vincristine) in patients with relapsed small cell lung cancer: a randomized phase II study of GFPC 0501Radj Gervais, Hervé Le Caer, Isabelle Monnet, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 2, 2008
Randomized multicenter phase II study of larotaxel (XRP9881) in combination with cisplatin or gemcitabine as first-line chemotherapy in nonirradiable stage IIIB or stage IV non-small cell lung cancerPetr Zatloukal, Radj Gervais, Johan Vansteenkiste, et al.
Pageof 9